A citation-based method for searching scientific literature

Claire Baker, Suman Wason, Phillip Banks, Sangeeta Sawhney, Anna Chang, Thomas Danne, Diane Gesty-Palmer, Jake A Kushner, Darren K McGuire, Frank Mikell, Mark O'Neill, Anne L Peters, Paul Strumph. Diabetes Obes Metab 2019
Times Cited: 11







List of co-cited articles
56 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.
Elke R Fährmann, Laura Adkins, Cameron J Loader, Hyoil Han, Kevin M Rice, James Denvir, Henry K Driscoll. Diabetes Res Clin Pract 2015
21
9


Population Pharmacokinetic- Pharmacodynamic Analysis to Characterize the Effect of Empagliflozin on Renal Glucose Threshold in Patients With Type 1 Diabetes Mellitus.
John Mondick, Matthew Riggs, Stefan Kaspers, Nima Soleymanlou, Jan Marquard, Valerie Nock. J Clin Pharmacol 2018
6
16

Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4-week, double-blind, randomized, placebo-controlled phase 2 trial.
Akira Shimada, Toshiaki Hanafusa, Atsutaka Yasui, Ganghyuck Lee, Yusuke Taneda, Akiko Sarashina, Kosuke Shiki, Jyothis George, Nima Soleymanlou, Jan Marquard. Diabetes Obes Metab 2018
19
9

Effectiveness and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus: A protocol for Systematic review and Meta-analysis.
Mao-Bing Chen, Rui-Jun Xu, Qi-Han Zheng, Xu-Wen Zheng, Hua Wang, Yun-Long Ding, Mao-Xing Yue. Medicine (Baltimore) 2019
1
100

Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis.
Jiali Liu, Ling Li, Sheyu Li, Pengli Jia, Ke Deng, Wenwen Chen, Xin Sun. Sci Rep 2017
77
9

SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials.
Robert Puckrin, Marie-Philippe Saltiel, Pauline Reynier, Laurent Azoulay, Oriana H Y Yu, Kristian B Filion. Acta Diabetol 2018
69
9

Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data.
Edward W Gregg, Yiling J Cheng, Meera Srinivasan, Ji Lin, Linda S Geiss, Ann L Albright, Giuseppina Imperatore. Lancet 2018
147
9

Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled trial.
Chantal Mathieu, Gottfried Rudofsky, Moshe Phillip, Eiichi Araki, Marcus Lind, Niki Arya, Fredrik Thorén, Markus F Scheerer, Nayyar Iqbal, Paresh Dandona. Diabetes Obes Metab 2020
14
9

Lower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM.
Aya Osaki, Yoko Shimoda, Junichi Okada, Eijiro Yamada, Tsugumichi Saito, Yasuyo Nakajima, Atsushi Ozawa, Yawara Niijima, Shuichi Okada, Masanobu Yamada. Diabetes Ther 2019
1
100

External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes.
S van Dieren, L M Peelen, U Nöthlings, Y T van der Schouw, G E H M Rutten, A M W Spijkerman, D L van der A, D Sluik, H Boeing, K G M Moons,[...]. Diabetologia 2011
51
9

Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus.
Mojca Lunder, Miodrag Janić, Miha Japelj, Andrej Juretič, Andrej Janež, Mišo Šabovič. Cardiovasc Diabetol 2018
30
9

Type 1 diabetes at a crossroads!
William T Cefalu, William V Tamborlane, Jay S Skyler. Diabetes Care 2015
9
11

Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.
Elizabeth J Mayer-Davis, Jean M Lawrence, Dana Dabelea, Jasmin Divers, Scott Isom, Lawrence Dolan, Giuseppina Imperatore, Barbara Linder, Santica Marcovina, David J Pettitt,[...]. N Engl J Med 2017
551
9

Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption.
David R Powell, Brian Zambrowicz, Linda Morrow, Carine Beysen, Marcus Hompesch, Scott Turner, Marc Hellerstein, Phillip Banks, Paul Strumph, Pablo Lapuerta. J Clin Endocrinol Metab 2020
10
10

Renoprotective effects of sodium-glucose cotransporter-2 inhibitors.
Hiddo J L Heerspink, Mikhail Kosiborod, Silvio E Inzucchi, David Z I Cherney. Kidney Int 2018
118
9


Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin.
Jan Bolinder, Östen Ljunggren, Joel Kullberg, Lars Johansson, John Wilding, Anna Maria Langkilde, Jennifer Sugg, Shamik Parikh. J Clin Endocrinol Metab 2012
466
9

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. BMJ 2009
9

The beneficial effects of modest weight loss on cardiovascular risk factors.
L F Van Gaal, M A Wauters, I H De Leeuw. Int J Obes Relat Metab Disord 1997
206
9



Dapagliflozin treatment for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.
Mei Zhang, Lin Zhang, Bin Wu, Haolan Song, Zhenmei An, Shuangqing Li. Diabetes Metab Res Rev 2014
81
9


Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members.
Jian Chen, Sandy Williams, Samantha Ho, Howard Loraine, Deborah Hagan, Jean M Whaley, John N Feder. Diabetes Ther 2010
150
9


SGLT2 inhibition--a novel strategy for diabetes treatment.
Edward C Chao, Robert R Henry. Nat Rev Drug Discov 2010
398
9

Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes.
Rena R Wing, Wei Lang, Thomas A Wadden, Monika Safford, William C Knowler, Alain G Bertoni, James O Hill, Frederick L Brancati, Anne Peters, Lynne Wagenknecht. Diabetes Care 2011
815
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.